People: SINRON MEDIKAL BE`AM (ELOS.O)

ELOS.O on Nasdaq

9.10USD
9 Feb 2010
Price Change (% chg)

$-0.16 (-1.73%)
Prev Close
$9.10
Open
--
Day's High
$9.35
Day's Low
$9.06
Volume
169,454
Avg. Vol
140,829
52-wk High
$12.44
52-wk Low
$4.55

view people for:

Summary

Name Age Since Current Position
Eckhouse, Shimon 64 2004 Chairman of the Board
Scafuri, Louis 57 2009 Chief Executive Officer
Tenenbaum, Fabian 35 2007 Chief Financial Officer
Schlachet, David 64 2007 Director
Butler, Marshall 82 2003 Director
Suesskind, Dan 65 2004 External Director
Anghel, Michael 70 2004 External Director
Krindel, Yaffa 54 2005 Director
» Insider Trading

Biographies

Name Description
Eckhouse, Shimon Dr. Shimon Eckhouse is Chairman of the Board of Directors of Syneron Medical Ltd., since May 2004. Dr. Eckhouse is the chairman of OrSense Ltd., CardioDex Ltd., NanoCyte Ltd., ColorChip Ltd., Ventor Medical Technologies Ltd., Tulip Ltd., and Navotek Ltd. Dr. Eckhouse was a co-founder of ColorChip and served as its chairman from 2003 to January 2004 and again since 2007, and as its chief executive officer from 2001 to 2003. Dr. Eckhouse was the chairman and chief executive officer of ESC Medical Systems from its inception in 1992 until 1999. Prior to founding ESC Medical Systems, Dr. Eckhouse was head of product development and technical director at Maxwell Technologies in San Diego, California. Before that, Dr. Eckhouse was a scientist, team leader and head of a department in Rafael, Armament Development Authority of Israel and was active in various areas of research and development, including lasers and electro-optics. Dr. Eckhouse holds a B.Sc. in physics from the Technion Israeli Institute of Technology and a Ph.D. in physics from the University of California at Irvine. He has more than 20 registered patents and published more than 50 papers in reference journals and conferences. He is also a member of the board of directors of the Technion Israeli Institute of Technology.
Scafuri, Louis Mr. Lou P. Scafuri is Chief Executive Officer of Syneron Medical Ltd., since February 2, 2009. From 1983 until 1999, Mr. Scafuri held various executive and sales positions with GE Marquette Medical Systems. In his last position with GE Marquette Medical Systems, Mr. Scafuri served as its COO and President. From 1999 to 2001, Mr. Scafuri served as the COO of ESC Medical, where he was in charge of the global sales, R&D and Operations of the company. From 2002, Mr. Scafuri acted as an entrepreneur and angel investor in medical device and medical aesthetic companies in the U.S. Mr. Scafuri holds a B.Sc. degree in biology from Cornell University in Ithaca, NY.
Tenenbaum, Fabian Mr. Fabian Tenenbaum is Chief Financial Officer of Syneron Medical Ltd. since May 14, 2007. Mr. Tenenbaum served as Vice President for Business Development since September 2006 and was responsible for developing the growth strategy for home-use product, which culminated in the exclusive worldwide joint development and supply agreement with Procter and Gamble. From April 2002 to September 2006, Mr. Tenenbaum was Vice President at Radiancy Inc., where he managed the U.S. subsidiary of a late-stage med-tech start-up with the third largest global installed base for light-based devices in the field of dermatology and aesthetic medicine. Mr. Tenenbaum holds a Bachelor’s degree in Medicine from Ben Gurion University and an MBA from Columbia Business School.
Schlachet, David Mr. David Schlachet is Director of Syneron Medical Ltd. Mr. Schlachet served as Chief Executive Officer from November 2005 until May 14, 2007, when he resigned as Chief Executive Officer and was appointed to board of directors. From July 2004 to November 2005, Mr. Schlachet served as Chief Financial Officer. From 2000 to June 2004, Mr. Schlachet served as Managing Partner of Biocom, a venture capital fund specializing in the life sciences area. From 1995 to 2000, Mr. Schlachet served as a senior Vice President and Chief Financial Officer of Strauss Elite Holdings, a packaged food group. From June 1997 to June 2000 David Schlachet also served as an active chairman of Elite Industries, a chocolate and confectionary company which is a subsidiary of Strauss Elite Holdings, in addition to his position in Straus Elite Holdings. From 1990 to 1995, Mr. Schlachet served as Vice President of Finance and Administration of the Weizmann Institute of Science. Mr. Schlachet serves as a director for Nasdaq listed EzChip (formerly LanOptics Ltd.). In addition, Mr. Schlachet serves as a director for Tel-Aviv Stock Exchange listed companies Taya Investments Ltd., Mazor Surgical Technologies Ltd. and Adgar Investments and Developments Ltd. As of November 2008, Mr. Schlachet was nominated to serve as a director in the Tel Aviv Stock Exchange (TASE) and as a director and audit committee member of the TASE Clearing House. Mr. Schlachet also serves as a director of several privately owned Israeli companies. Mr. Schlachet holds a B.Sc. degree in chemical engineering and an M.B.A. from Tel-Aviv University.
Butler, Marshall Mr. Marshall Butler is Director of Syneron Medical Ltd., since October 2003. Mr. Butler is a co-founder and has served as chairman of both First Israel Mezzanine Investors Fund and Israeli Infinity Venture Capital Fund since 1996. Mr. Butler is a director of Pixer Technology Ltd., and A.R.T. New York. Mr. Butler served as chairman of Nitzanim, AVX/Kyocera Corporation from 1994 to 2001. Mr. Butler served as Chief Executive Officer and chairman of AVX Corporation from 1974 to 1993 and as director of Kyocera Corporation from 1990 to 1994. Mr. Butler is on the board of governors of the Technion Institute in Haifa, Israel. In 1998, Mr. Butler received the Israeli Prime Minister’s award for his contribution to Israeli industry. In 2001, he received an Honoree Doctorate from the Technion Institute.
Suesskind, Dan Mr. Dan Suesskind is Director of Syneron Medical Ltd., since November 2004. Until 2008, Mr. Suesskind has held numerous positions with Teva Pharmaceutical Industries Ltd. since 1976. Mr. Suesskind served as Teva’s Chief Financial Officer from 1977 until 2008, and as a director from 1981 until 2001. From 1970 until 1976, Mr. Suesskind was a consultant and securities analyst with I.C. International Consultants Ltd. Mr. Suesskind is a member of the Jerusalem Foundation, Investment Advisory Committee, Board of Trustees of Hebrew University, board member of Ness Technologies Inc., and a board member of Migdal Insurance Company Ltd. Mr. Suesskind received his B.A. in Economics and Political Science from the Hebrew University in 1965, a certificate in Business Administration from the Hebrew University in 1967, and an M.B.A. from the University of Massachusetts in 1969.
Anghel, Michael Dr. Michael J. Anghel is Director of Syneron Medical Ltd., since November 2004. Until 2005, Dr. Anghel served as the President and CEO of Israel Discount Capital Markets & Investments Corp., a subsidiary of the Israel Discount Bank. From 2000 to 2004, Dr. Anghel served as the Chief Executive Officer of CAP Ventures, an operating venture capital company he founded that has invested and established a number of information technology and communications enterprises. Since 1980, Dr. Anghel has been directly involved in founding, managing and directing a variety of industrial, technology and financial enterprises. Dr. Anghel also served as a director of major publicly listed corporations and a number of financial institutions and providence funds. Dr. Anghel is currently a director of Evogene Ltd., Dan Hotels Ltd., Analyst Provident Fund, Partner Communications Company Ltd., Straus Group and several other private companies, including Gravity Visual Effects & Design Ltd. From 1969 to 1977, Dr. Anghel was a full-time member of the faculty of the Graduate School of Business at the Tel-Aviv University teaching in the areas of finance and corporate strategy. Dr. Anghel served on various Israeli governmental policy committees in the areas of communications and public finance. Dr. Anghel is the Chairman of the Executive Program of the Graduate School of Business Administration of Tel Aviv University. Dr. Anghel received his B.A. in Economics from the Hebrew University in 1960, an M.B.A. in Economics and Finance from Columbia University in 1964, and a Ph.D. in International Finance from Columbia University in 1969.
Krindel, Yaffa Ms. Yaffa Krindel is Director of Syneron Medical Ltd., since November 2005. She is currently serving as a General Partner in Tamarix Ventures, a private cleantech venture capital partnership headquartered in Herzliya, Israel. From 1997 until 2007 Ms. Krindel served as Partner and Managing Partner of Star Ventures, a private venture capital fund headquartered in Munich, Germany. Before joining Star Ventures, between 1992 and 1996, Ms. Krindel served as CFO and VP Finance of Lannet Data Communications Ltd., then a publicly traded company in NASDAQ (now part of Avaya Inc.), a data communication systems company for the enterprise market. From 1993 to 1997 she served as a director and CFO of BreezeCOM Ltd. (now part of Alvarion Ltd.), a Point-to-Multipoint (PMP) Broadband Wireless Access company headquartered in Tel Aviv. Ms. Krindel currently serves on the boards of : Fundtech Ltd. (NASDAQ: FNDT), Voltaire Ltd. (NASDAQ: VOLT), OrSense Ltd. and Siano Inc. Ms. Krindel has earned M.B.A. from Tel Aviv University and a B.A. in Economics and Japanese Studies from the Hebrew University in Jerusalem.

Basic Compensation

Name Fiscal Year Total
Eckhouse, Shimon --
Scafuri, Louis --
Tenenbaum, Fabian --
Schlachet, David --
Butler, Marshall --
Suesskind, Dan --
Anghel, Michael --
Krindel, Yaffa --
As Of 

Insider Trading

» Full list on Insider Trading
view people for: